Rosenberger Brian
Insider CIK 1695788 · ZYNE VP, Commercial & Business Dev.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 90,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 300,000 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 69,559 | — | $0 | 180,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-10-10 | 2023-10-11 | 120,000 | — | $0 | 300,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-09-13 | 2023-09-14 | 6,411 | $1.33 | $8.5K | 249,559 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-09-12 | 2023-09-14 | 22,200 | — | $0 | 255,970 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-08 | 2023-02-09 | 5,145 | $0.60 | $3.1K | 233,770 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-02-07 | 2023-02-09 | 14,926 | — | $0 | 238,915 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | F Tax w/h | 2023-02-01 | 2023-02-02 | 4,809 | $0.60 | $2.9K | 223,989 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-31 | 2023-02-02 | 13,950 | — | $0 | 228,798 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-01-24 | 2023-01-25 | 120,000 | — | $0 | 214,848 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-01-23 | 2023-01-25 | 12,663 | $0.60 | $7.6K | 94,848 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-07-19 | 2022-07-20 | 4,289 | $1.10 | $4.7K | 107,511 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-07-18 | 2022-07-20 | 14,800 | — | $0 | 111,800 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-01-26 | 2022-01-28 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-01-26 | 2022-01-28 | 60,000 | — | $0 | 97,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-01-21 | 2021-01-25 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-01-21 | 2021-01-25 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-01-30 | 2020-02-03 | 48,000 | — | $0 | 48,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-01-30 | 2020-02-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-01-24 | 2019-01-28 | 42,287 | — | $0 | 42,287 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-01-11 | 2018-01-16 | 42,000 | — | $0 | 42,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-01-18 | 2017-01-25 | 37,500 | — | $0 | 37,500 | SEC↗ |